Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,072 public trials 1,364 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Recruiting

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07702292

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Lombardy, Italy
  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore Roma, Italy
  • IRCCS Ospedale San Raffaele Milan, Segrate, Italy
View Trial Details
Recruiting

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

NCT06937177

Conditions
Body Weight, Body Weight Changes, Cachexia, +20 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Medical Center Santa Monica, California, United States
  • Life Clinical Trials Coral Springs, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

NCT07286266

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Hyōgo, Japan
View Trial Details
Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

NCT05053971

Conditions
Advanced Malignant Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Recruiting

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer

NCT07278336

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Sarah Cannon Research Institute at HealthONE /ID# 278785 Denver, Colorado, United States
  • University of Chicago Medical Center /ID# 278295 Chicago, Illinois, United States
  • NEXT Oncology - San Antonio /ID# 278606 San Antonio, Texas, United States
  • Start Mountain Region /ID# 278609 West Valley City, Utah, United States
View all 17 locations
View Trial Details

Related conditions